Cervical Plexus Block (CPB) in Whiplash Associated Disorder (WAD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04622020 |
|
Recruitment Status :
Recruiting
First Posted : November 9, 2020
Last Update Posted : November 9, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Whiplash is the most common injury associated with motor vehicle accidents and a major cause of disability and litigation. An acute whiplash injury follows sudden or excessive hyperextension, hyper flexion, or rotation of the neck affecting the soft tissues. It typically results from rear-end or side-impact motor vehicle collisions. Patients commonly present with pain and stiffness in the neck, headache, and upper backache. Chronic whiplash syndrome is characterized by symptoms of neck pain that persist for more than 3 months (1, 2). With over half a million people making whiplash injury claims per annum in the UK, it has a major impact on the healthcare and legal systems and also the economy. Over 40% of patients with whiplash injury report chronic neck pain and this is often refractory to conservative management (pain relief medications, physiotherapy). Current treatment involves burning the small nerves that supply the joints (facet joints) in the neck. Although they provide pain relief that can last 6-9 months, the nerves re-grow and the treatment has to be repeated. This treatment is a complex procedure that requires extensive training and has the potential to cause serious harm. There is new evidence to show that the pain in whiplash injury could be due to an impaired function of the neck muscles arising from whiplash trauma. Current treatment for this condition is injection of numbing medicine or steroids directly into the muscle. Although this treatment is safer than burning the facet nerves, it provides short-term relief.
The investigators have shown that a novel treatment targeting the nerves that supply the muscles in the neck can provide durable relief in patients with chronic neck pain. The medication is injected into a specific area (plane) in the neck of the patient and is called cervical plexus block (CPB). The investigators currently offer CBP treatment as a standard treatment in the management of patients with chronic neck pain arising from whiplash injury. There are two types of CPB: CPB with numbing medicine (CPB-LA) and CPB with steroid.
Aim of the study is to evaluate the effectiveness of two types of Cervical Plexus Block (CPB) treatment in reducing pain at three months in patients with refractory chronic neck pain from whiplash injury
Methods: The proposed study is a prospective, observational pilot study that will be conducted at Leicester General Hospital over 36 months. Potential participants will be given an information sheet by the clinical team when they are seen in the outpatient clinic. The participants will have 24 hours to read the information sheet. Thereafter, the research team will approach the potential participant to obtain informed consent. After providing written consent, adult patients with chronic neck pain from whiplash injury will receive ultrasound guided CPB-LA in the theatre. If treatment provides >30% relief at 3 months, they will be re-assessed at six months and CPB-LAi will be repeated as per waiting list. If at 3 months, the pain returns to the baseline, CPB with steroid will be performed. If CPB with steroid does not provide any benefit, the participants will receive a rescue treatment (trigger point injection) within three months. Participants will be asked to complete questionnaires on pain scores and mood. Participation in the study will end at 9 months following the first CPB treatment on completion of relevant questionnaires.
| Condition or disease | Intervention/treatment |
|---|---|
| Whiplash Associated Disorder | Procedure: Cervical Plexus Block with Local Anaesthesia Procedure: Cervical Plexus Block with Depot Steroids |
Whiplash is the most common injury associated with motor vehicle accidents and a major cause of disability and litigation. An acute whiplash injury follows sudden or excessive hyperextension, hyper flexion, or rotation of the neck affecting the soft tissues. It typically results from rear-end or side-impact motor vehicle collisions. Patients commonly present with pain and stiffness in the neck, headache, and upper backache with or without paraesthesia of the upper limbs. Chronic whiplash syndrome is characterized by symptoms that persist for more than 3 months. With over half a million people making whiplash injury claims per annum in the UK, it has a major impact on the healthcare and legal systems and also the economy. In 1995, whiplash-associated disorder (WAD) was defined by the Quebec task force as 'Whiplash is an acceleration-deceleration mechanism of energy transfer to the neck. The incidence of WAD is very variable, averaging to about 9 per 1000 people in the UK, the highest in Europe.
Around 40% of patients suffer from symptoms of WAD beyond 3 months (chronic whiplash) and 2 - 4.5% of patients are left permanently disabled.
There is evidence that neck pain in WAD could arise from either cervical facet joint or due to impaired function of neck muscles (Cervicothoracic Myofascial Pain Syndrome, CTMPS) or both. The investigators have recently reported on ultrasound guided cervical plexus block with depot steroids in the management of refractory cervicothoracic myofascial pain. This intervention involves a single injection that targets a number of muscles that are commonly involved in causing chronic WAD. The treatment has a definite end point that helps to standardize the intervention with a good safety profile.
The present study is an observational study on the effectiveness of two types of cervical plexus block (CPB-Local Anaesthesia and CPB-Steroids) treatment as a part of standard care in providing durable analgesia. The objective is to collect data to inform the design a larger multicentre study
| Study Type : | Observational |
| Estimated Enrollment : | 36 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Effectiveness of Ultrasound Guided Intermediate Cervical Plexus Block (iCPB) in Patients With Refractory Chronic Neck Pain From Whiplash Associated Disorder (WAD): an Observational Study |
| Actual Study Start Date : | June 26, 2020 |
| Estimated Primary Completion Date : | February 26, 2023 |
| Estimated Study Completion Date : | June 26, 2023 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Adult patients with chronic neck pain (> 3 months) following whiplash injury
Cervical plexus block with local anaesthesia followed by Cervical Plexus block with depot steroids
|
Procedure: Cervical Plexus Block with Local Anaesthesia
Ultrasound guided intermediate cervical plexus block Procedure: Cervical Plexus Block with Depot Steroids Ultrasound guided intermediate cervical plexus block |
- Primary outcome will be Pain at its Worst in the last 24 hours at the baseline and 3 months following the interventional treatment [ Time Frame: 3 months ]Effective outcome: A two-point change in the Numerical Rating Scale (Pain at its worst in the last 24 hours) at three months when compared to the baseline. The Pain at its worst in 24 hours will be measured on the Brief Pain Inventory-short form (BPI-SF) question number 3 on Brief Pain Inventory -short form questionnaire. The expected change is a
- Treatment Failure rate: absence of sustained benefit at three month follow up [ Time Frame: 3 months ]No reduction in NRS 'Pain at its worst in the last 24 hours' at three months when compared to the baseline NRS
- Pain at its Worst in the last 24 hours at the baseline and 6 months [ Time Frame: 6 months ]Change in the Pain at its worst score at 6 months when compared to the baseline
- Change in Neck Disability Index (NDI) at 3 and 6 months when compared to baseline [ Time Frame: 6 months ]Change in neck disability index at three and 6 months when compared to the baseline scoree that is measured on the NDI questionnaire
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 90 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All patients aged over 18 years and under 90 years willing to consent
- History of whiplash injury
- Chronic neck pain for above 3 months
- Moderate to severe pain in the neck: Baseline NRS >4 (worst pain the last 24 hours)
Exclusion Criteria:
- Lack of consent, including from those patients who lack mental capacity to give informed consent.
- Past History of chronic neck pain that was present before suffering a whiplash injury
- Patients with known history of drug allergy to depomedrone
- Patients with infection at injection site at on day of treatment
- Patients aged under 18 years or over 90 years
- Unwilling to provide consent
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04622020
| Contact: G Niraj Dr, MD | +44 1162588253 | niraj.g@nihr.ac.uk |
| United Kingdom | |
| University Hospitals of Leicester NHS Trust | Recruiting |
| Leicester, United Kingdom | |
| Contact: Niraj G Dr, MD | |
| Principal Investigator: | G Niraj, MD | University Hospitals, Leicester |
| Responsible Party: | University Hospitals, Leicester |
| ClinicalTrials.gov Identifier: | NCT04622020 |
| Other Study ID Numbers: |
EDGE 129250 |
| First Posted: | November 9, 2020 Key Record Dates |
| Last Update Posted: | November 9, 2020 |
| Last Verified: | November 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Cervical Plexus Block Whiplash injury WAD |
|
Whiplash Injuries Neck Injuries Wounds and Injuries |
Anesthetics Central Nervous System Depressants Physiological Effects of Drugs |

